Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model

BACKGROUND: While there is an evidence that the anti-inflammatory properties of spironolactone can attenuate proteinuria in type 2 diabetes, its effects on vascular endothelial growth factor (VEGF) expression in diabetic nephropathy have not been clearly defined. In this study, we examined the effec...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lee, Mi Young, Shim, Myoung Sook, Kim, Bo Hwan, Hong, Soon Won, Choi, Ran, Lee, Eun Young, Nam, Soo Min, Kim, Gun Woo, Shin, Jang Yel, Shin, Young Goo, Chung, Choon Hee
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Diabetes Association 2011
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122897/
https://ncbi.nlm.nih.gov/pubmed/21738895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2011.35.2.130
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky